State Street’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $453K | Sell |
|
|||||
|
2025
Q1 | $736K | Sell |
|
|||||
|
2024
Q4 | $5.12M | Buy |
|
|||||
|
2024
Q3 | $576K | Buy |
|
|||||
|
2024
Q2 | $186K | Sell |
|
|||||
|
2024
Q1 | $1.84M | Buy |
|
|||||
|
2023
Q4 | $1.47M | Buy |
|
|||||
|
2023
Q3 | $1.61M | Buy |
|
|||||
|
2023
Q2 | $3.45M | Sell |
|
|||||
|
2023
Q1 | $15.8M | Sell |
|
|||||
|
2022
Q4 | $30.7M | Buy |
|
|||||
|
2022
Q3 | $34.1M | Sell |
|
|||||
|
2022
Q2 | $32M | Sell |
|
|||||
|
2022
Q1 | $45.2M | Buy |
|
|||||
|
2021
Q4 | $46.5M | Buy |
|
|||||
|
2021
Q3 | $52.9M | Sell |
|
|||||
|
2021
Q2 | $71.8M | Sell |
|
|||||
|
2021
Q1 | $82M | Buy |
|
|||||
|
2020
Q4 | $99.5M | Sell |
|
|||||
|
2020
Q3 | $66.4M | Buy |
|
|||||
|
2020
Q2 | $58.1M | Buy |
|
|||||
|
2020
Q1 | $30.9M | Buy |
|
|||||
|
2019
Q4 | $40.3M | Sell |
|
|||||
|
2019
Q3 | $45.4M | Sell |
|
|||||
|
2019
Q2 | $57.6M | Sell |
|
|||||
|
2019
Q1 | $55.8M | Sell |
|
|||||
|
2018
Q4 | $67.8M | Sell |
|
|||||
|
2018
Q3 | $110M | Buy |
|
|||||
|
2018
Q2 | $86.3M | Buy |
|
|||||
|
2018
Q1 | $86.2M | Buy |
|
|||||
|
2017
Q4 | $65.3M | Buy |
|
|||||
|
2017
Q3 | $43.4M | Buy |
|
|||||
|
2017
Q2 | $16.4M | Buy |
|
|||||
|
2017
Q1 | $6.41M | Buy |
|
|||||
|
2016
Q4 | $3.61M | Sell |
|
|||||
|
2016
Q3 | $11.2M | Buy |
|
|||||
|
2016
Q2 | $11M | Sell |
|
|||||
|
2016
Q1 | $13.6M | Buy |
|
|||||
|
2015
Q4 | $16.9M | Sell |
|
|||||
|
2015
Q3 | $23.9M | Buy |
|
|||||
|
2015
Q2 | $37.7M | Buy |
|
|||||
|
2015
Q1 | $39.5M | Buy |
|
|||||
|
2014
Q4 | $35.4M | Sell |
|
|||||
|
2014
Q3 | $27.3M | Buy |
|
|||||
|
2014
Q2 | $32.4M | Buy |
|
|||||
|
2014
Q1 | $34.4M | Sell |
|
|||||
|
2013
Q4 | $31.6M | Buy |
|
|||||
|
2013
Q3 | $22.6M | Sell |
|
|||||
|
2013
Q2 | $21.2M | Buy |
|